ID
22329
Description
A Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Rosiglitazone (Extended Release Tablets) on Cerebral Glucose Utilization and Cognition in Subjects With Mild to Moderate Alzheimer's Disease (AD) Medicine: rosiglitazone, Condition: Alzheimer's Disease, Phase: 2, Clinical Study ID: 49653/461, This form is to be performed after 2 weeks. Sponsor: GSK Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00265148?term=NCT00265148&rank=1
Lien
https://clinicaltrials.gov/ct2/show/NCT00265148?term=NCT00265148&rank=1
Mots-clés
Versions (1)
- 30/05/2017 30/05/2017 -
Téléchargé le
30 mai 2017
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Baseline Signs and Symptoms Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148
Baseline Signs and Symptoms Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148
Description
Baseline Signs and Symptoms
Alias
- UMLS CUI-1
- C0877248
- UMLS CUI-2
- C0037088
Description
Diagnosis
Type de données
text
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0011900
Description
Onset Date and Time
Type de données
datetime
Alias
- UMLS CUI [1]
- C2985916
Description
Outcome
Type de données
integer
Alias
- UMLS CUI [1]
- C1705586
Description
Course
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0750729
Description
Episode
Type de données
float
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0332189
Description
Intensity
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0522510
- UMLS CUI [1,2]
- C0877248
Description
trial procedures
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0008976
- UMLS CUI [1,2]
- C2700391
Description
Corrective Therapy
Type de données
boolean
Alias
- UMLS CUI [1]
- C0087111
Description
Withdrawal
Type de données
boolean
Alias
- UMLS CUI [1]
- C2349954
Similar models
Baseline Signs and Symptoms Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148
C0037088 (UMLS CUI-2)
C0011900 (UMLS CUI [1,2])
C0332189 (UMLS CUI [1,2])
C2700391 (UMLS CUI [1,2])